The 23 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 53.76, with a high estimate of 58.68 and a low estimate of 38.33. The median estimate represents a +20.33% increase from the last price of 44.68.
The current consensus among 26 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.45
Reporting Date Apr 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.